INSM · Insmed Inc
United States · RS rating 14 · As of 2026-10-14
| Price | 97.79 USD |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 13 / 34 / 17 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 37 / 16 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +12.0% |
| Sales growth Q/Q | +85.4% |
| Distance from 52-week high | +53.7% |
| Market cap (USD) | $31.0B |